How Protocol Complexity Quietly Drains Your Enrollment Funnel

Protocol complexity is usually discussed as a budget problem. It is also a recruitment problem, and sites feel it long before the sponsor sees a flat enrollment curve. Every additional procedure, visit, and exclusion criterion narrows the funnel somewhere — at the eligibility screen, at the consent conversation, or at the first long visit.

Where complexity actually costs you patients

In most site datasets, complex protocols lose patients at three predictable points.

Pre-screen attrition from criteria stacking. A protocol with twenty-five exclusion criteria doesn't just exclude more people — it makes accurate pre-screening harder. Coordinators either over-screen (burning phone time on people who will fail at the lab) or under-screen (sending unqualified patients to a costly screening visit). Both inflate your screen-fail rate.

Consent attrition from visit burden. Patients rarely decline because of risk language. They decline because the schedule of assessments requires eleven visits, three of which run six hours, during business hours, at a site forty minutes from home. If the burden lands during the consent conversation as a surprise, you lose someone you already spent money recruiting.

Post-enrollment attrition from procedure fatigue. Daily diaries, device wear, washout periods, and repeat biopsies drive withdrawals in month two and three. Those are recruitment losses too — you have to replace them.

Read the protocol like a recruiter, not just a coordinator

Before feasibility, pull three things out of the draft protocol:

1. The effective eligible population. Not the indication, but the indication after exclusions. Washouts, prior-therapy limits, and lab thresholds often cut a seemingly large population to a narrow slice. Check it against your own chart data before you commit to a number.
2. Visit burden per participant. Total visit count, longest visit duration, and how many require fasting or an escort. Anything over roughly half a day repeatedly is a retention risk.
3. Who the protocol excludes structurally. Strict contraception requirements, smartphone dependency for ePRO, English-only materials, and no-caregiver-allowed visits all quietly narrow your demographic reach.

What to push back on during feasibility

Sponsors expect operational feedback and often accept it, especially before final protocol lock. Be specific and evidence-based.

• Flag exclusion criteria that your chart review shows would disqualify a large share of your otherwise-eligible patients. Name the criterion and the approximate proportion.
• Ask whether a lab threshold can be widened or a screening window extended. A seven-day screening window with a central lab turnaround of five days is a scheduling trap.
• Request that burdensome assessments be consolidated into fewer visits rather than spread across many.
• Ask about remote or home-health options for assessments that don't require the site.

Adjust your recruitment plan to match the complexity

When complexity is fixed, change your approach instead of your expectations.

Pre-screen harder and earlier. Build a pre-screening script that front-loads the three or four criteria that disqualify the most people. Ask them first, not last.

Disclose burden before consent. Put the visit count, longest visit, and key procedures into your first substantive conversation. You will lose some candidates earlier — that is the point. The ones who continue are far more likely to complete.

Budget more touches per enrollment. Complex trials need a larger top-of-funnel and more coordinator time per patient. If your referral volume assumptions were built on simpler studies, they will not hold.

Track screen-fail reasons individually. Coded, countable screen-fail reasons let you tell the sponsor exactly which criterion is costing enrollment — the single most persuasive argument for a protocol amendment.